The milbemycins, a group of potent, broad-spectrum antiparasitic and pesticidal agents, are architecturally novel antibiotics of 16-membered macrocyclic lactone. Seven new milbemycin analogues designated as milbemycins D, E, F, G, H, J and K were isolated from the fermentation broth of the mutant strain of Streptomyces hygroscopicus subsp. aureolacrimosus. The structural determination of these new components was made mainly by comparing with mass spectra, and 114 and 13C NMR spectra of milbemycin a-and (9-series previously published from our laboratory. Milbemycins D, E, F, G and H have characteristically an isopropyl side chain at C-25 which differs from the known milbemycin family bearing methyl or ethyl group at C-25. Milbemycins J and K possess a ketone group at C-5 instead of a hydroxyl or methoxy group.
Milbemycins1-3), which was found and structurally elucidated in 1975 in our laboratory as shown in Fig. 1 , is a group of the fermentation products of Streptomyces hygroscopicus subsp. aureolacrimosus with potent, broad-spectrum anthelmintic, insecticidal and acaricidal activity, but is devoid of the antibacterial activity associated with macrolide derivatives. Common characteristic feature of the milbemycin is the presence of both a 6,6-membered spiroketal and a cyclohexene ring fused to the 16-membered macrocyclic lactone ring. Milbemycins can be divided structurally into two groups of a-and Qseries: a-series has the tetrahydrofuran ring fused to the cyclohexene ring, (l-series has no tetrahydrofuran ring. After several years of our finding milbemycins, the Merck group reported on the avermectins, isolated from the fermentation broth of Streptomyces avermitilis, which were glycosides with an a-L-oleandosyl-a-L-oleandosyl moiety at C-13 of milbemycin, and showed a similar biological activity to that of the milbemycin4, 5) In the course of our fermentation development, novel milbemycin analogues designated as milbemycins D, E, F, G, H, J and K were obtained from the fermentation broth of the mutant strain of S.
hygroscopicus subsp. aureolacrimosus. The fermentation, isolation and physico-chemical properties of these new metabolites have been reported in the previous papers"').
In this paper we wish to report the structure determination of these new metabolites and the absolute configuration of milbemycin D. ** Present address: Fermentation Research Laboratories , Sankyo Co., Ltd., 1-12-1, Shibakubo, Tanashi, Tokyo 188, Japan
Results and Discussion
Structure of Milbemycins D, E, F, G. H. J and K
A number of over-all skeleton and structural elements of new components could be deduced mainly from analysis of their mass spectral fragmentation and 1H and 13C NMR spectral data. In the mass spectra of milbemycins, the appearance of a relatively intensive molecular ion and fragment ions resulted from allyl fission, ester elimination, a-cleavage adjacent to an oxygen atom and a retro Diels-Alder reaction was commonly observed. The formula of the molecular and diagnostically prominent ions were confirmed by high resolution mass spectral analysis. The interpretations of the mass spectral data shown in Schemes 1, 2, 3 and 4 were proved from the comparison with the mass spectra of the metabolites using 13C-labelled precursor in the biosynthetic studies as described in the accompanying paper8). which comprise the side chain at C-25, of milbemycin D were 28 and 14 mass units more than those of milbemycins a, and a3, respectively, while the ions h, i and j were unaffected by changes in the spiroketal portion of the molecule. Thus it can be concluded that a C3H7 group is attached at C-25 instead of the ethyl group of milbemycin a, and the methyl group of milbemycin a1. Milbemycin F Milbemycin F, amorphous, has the molecular formula of C38H51NO9 ( Table 1 ). The IR (v 3320, 1730 and 1710 cm-1) and UV [2] EtOHmax 245 nm (e 24,100) and 253 nm (s 21,400)] spectra of milbemycin F were substantially identical with those of milbemycins a0 and a10.
In the mass spectrum of milbemycin F, the bulk of the high mass fragments (ions b through j) agreed in detail with that of milbemycin D and the differentiation was the appearance of pyrrole carboxylic acid (C5H5NO2, m/z 111) and pyrrole carbonyl (C5H4NO, m/z 94) radicals (Table 1) . Accordingly the pyrrole ring should exist in the counterpart, suffered a retro Diels-Alder reaction, of species b (Scheme 1).
Further evidence for the pyrrole ester chain in F component was provided by the comparison of the NMR data: the C-4 methyl broad ringlet at 61.86 characteristic in D component was replaced by a broad singlet of the methylene group at 5 4.87 bearing oxygen atom. In both 1H and 13C NMR spectra, the existence of the pyrrole ring is confirmed by three multiplet signals at 5 6.18, 6.86 and 7.01 and by three peaks at 6 110.9, 116.6 and 121.3 assignable to j3, S and a-protons and to the three carbons of pyrrole ring, respectively. The 1H NMR was very similar to that of milbemycin a,, the difference being as quite equal downfield shift of proton signals at C-3 and C-6 as observed in the 1H NMR of milbemycin J.
In the mass spectrum as shown in Scheme 2, diagnostic ions a, b, c, d, e, f, and g at m/z 540, 522 , 504, 264, 195, 167 and 415 were 14 mass unit more than those of milbemycin J, and another prominent ion peaks at m/z 259, 241 and 151 formed from ions b, c and a by cleavage of C12-C1, bond were observed in both spectra. These data allows the conclusion that the structure of milbemycin K is a homo analogue at C-25 of milbemycin J as shown in Fig. 1 . Table   1 ). The IR (v 3490 and 1715 cm-1) and UV [2EtOHmax241 nm (r 26,000)] spectra were essentially identical with those of milbemycins ~1 and p2.
In the mass spectrum of milbemycin E, the fragment ions b, c, d and e derived from the rupture of mass spectrometrically fragile bond were observed at m/z 430, 278, 209 and 181 with the increased shift by 28 and 14 mass units compared with the corresponding ions in the spectrum of milbemycins P, and (,i respectively, while one of the important peaks was observed as a prominent peak having a following ion structure at m/z 294, which was unaffected by changes in the spiroketal portions of the molecule (Scheme 3).
In accordance with the mass data, the 1H NMR showed two doublets of methyl signals in the isopropyl group at 5 0.83 and 1.00 (each 3H, d).
These results clearly indicate that milbemycin E includes isopropyl radical as the side chain at C-25, and the structure was determined as depicted in Fig. 1 In order to directly establish the absolute configuration of the hydroxyl group at C-5 incorporated in the cyclic milbemycin D skeleton, the MILLS' rule") was employed together with CD allylic benzoate method"). (4) due to the steric hindrance of the tetrahydrofuran ring and/or the participation of the tertiary hydroxyl group at C-7. Alternatively, the 5-mesylate of milbemycin D was subjected to SN 2 displacement with tetraethylammonium formate followed by hydrolysis with NaHCO3, giving the epimeric alcohol (4) as shown in Scheme 5.
The specific rotations of milbemycin D ([a]D +105°) and its acetate (5) (+92°) were more levorotatory than the epimer ([a]D +132°) and its acetate (6) (+119°), respectively, showing that the stereochemistry of C-5 in milbemycin D is the R configuration. The same conclusion was also supported by CD measurement of the p-N,N-dimethylaminobenzoates (7 and 8). The CD spectrum of the benzoate of natural milbemycin D gave rise to a negative Cotton effect at 295 nm and the epimer at C-5 positive (Fig. 2) .
It comes to the conclusion that application of the empirical rules usually employed for deducing the absolute configurations of allylic alcohols to milbemycin D led to the formulations as shown in Fig. 1 . Fig. 2 . CD spectra of the benzoate of milbemycin D (1) and its epimeric isomer at C-5 (2) in ethanol solution.
Experimental
The new milbemycin analogues were amorphous or foams and were therefore purified by high performance column chromatography [Waters Corasil A column with eluting solvents of n-hexane -MeOH (100: 3. To the cold reaction mixture was added 1 ml of dilute acetic acid. After the usual workup with EtOAc, 17 mg of a crude milbemycin D as a foam was obtained.
It was purified by column chromatography on silica gel by elution with n-hexane -EtOAc (85: 15) to give 14 mg of milbemycin D (2), which was identified with the authentic sample.
5;3-O-Methanesulfonylmilbemycin D (3)
To a stirred solution of milbemycin D (1.112 g, 2 mmol) and triethylamine (600 mg, 6 mmol) in 10 ml of anhydrous tetrahydrofuran in an ice bath was added dropwise a solution of methanesulfonyl chloride (573 mg, 5 mmol) in 5 ml of anhydrous tetrahydrofuran.
After one hour at an ambient temperature, the usual workup with benzene gave 1.21 g of a crude 3 as a white amorphous product which was used to the further reaction. 
548-O-Acetylmilbemycin D (5)
A solution of milbemycin D (400 mg, 0.719 mmol) and 1 ml of acetic anhydride in 3 ml of pyridine was allowed to stand at room temperature overnight. The reaction mixture was poured into water. The usual workup with EtOAc gave a crude product, which was purified by column chromatography on silica gel by elution with n-hexane -EtOAc 
